Breaking New Ground
Improving outcomes for people with cancer by translating novel scientific insights into first-in-class immunotherapies
Resilient to Our Core
With grit, expertise and passion, our scientists are enabling transformational shifts in cancer treatment
We’re in this Together
We believe that through dedication and with teams that transcend corporate walls, we can transform patient lives
Recent News
October 14, 2021
Tizona Initiates Phase 1b Expansion Study of TTX-080 in Advanced Refractory or Resistant Malignancies
September 15, 2020
Tizona Appoints Christine O’Brien as Chief Executive Officer